Buschhave et al. (Buchhave et al., 2012) showed that Aβ42 performs better than Tau or structural MRI 5–10 years before conversion to AD, but T-tau and p-tau have better predictive power 0–5 years before conversion to AD. This evidence concerns the gene MAPT and Alzheimer disease.